Longwood Fund — 2019 Investments
2 investments dated 2019 · listed companies and verified rows first · show all
Boston, US
Board seatDavid SteinbergChristoph Westphal· per SEC Form D
Co-investorsRA CapitalAgent Capital
A company focused on developing clinical treatments aimed at improving patient outcomes.
BiotechHealthtechMedical DevicesBoston, US
David Southwell(Executive Officer, Director)Robert Crane(Executive Officer)
BoardSteve Kraus(Director)inCampbell Murray(Director)Hannes Smarason(Director)in
Board seatChristoph WestphalLea Hachigian· per SEC Form D
Co-investorsAstellas Venture Management LLCBessemer Venture PartnersRA Capital6 Dimensions CapitalLongwood Special SituationsPitango
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.